Longer-term use (6+ months) may create more durable improvements where enhanced dermal architecture supports ongoing collagen synthesis at rates intermediate between treatment peaks and pre-treatment baseline, potentially maintaining 40-60% of peak improvements indefinitely without continuous peptide application
Patients encountering online sources or private clinics offering this combination should exercise significant caution, as: Unregulated supply of investigational peptides carries serious safety risks Quality, purity, and dosing of unlicensed products cannot be guaranteed Use outside of a clinical trial setting is not supported by current evidence or regulatory frameworks For those seeking access to obesity treatments within a safe and monitored environment, NICE-approved pathways for existing licensed therapies remain the appropriate starting point
intramuscular administration Subcutaneous (into fatty tissue of abdomen, typically 1-2 inches lateral to navel, using a 25-27 gauge, 5/8-inch needle): 28% report injection-site soreness Easier for self-administration Slower absorption (peak serum B12 at 12-18 hours vs
This triple action covers the three pillars of skin regeneration: extracellular matrix + vascularization + cell migration
They support the structural repair that other peptides, like BPC-157 and GHK-Cu, promote through more direct mechanisms